These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37093650)

  • 21. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis.
    Kiryu J; Kita M; Tanabe T; Yamashiro K; Ieki Y; Miura S; Miyahara S; Tamura H; Honda Y
    Jpn J Ophthalmol; 2003; 47(5):479-83. PubMed ID: 12967864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of pars plana vitrectomy in the diagnosis and treatment of uveitis.
    Svozilkova P; Heissigerova J; Brichova M; Kalvodova B; Dvorak J; Rihova E
    Eur J Ophthalmol; 2011; 21(1):89-97. PubMed ID: 20853259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macular optical coherence tomography findings after vitreoretinal surgery for rhegmatogenous retinal detachment.
    Coppola M; Marchese A; Cicinelli MV; Rabiolo A; Giuffrè C; Gomarasca S; Querques G; Bandello F
    Eur J Ophthalmol; 2020 Jul; 30(4):805-816. PubMed ID: 32174150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of pars plana vitrectomy in the management and diagnosis of patients with infectious, non-infectious, and unidentified uveitis.
    Celiker H; Çam F; Özkoçak BY
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2237-2246. PubMed ID: 38363356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments.
    Moore JK; Scott IU; Flynn HW; Smiddy WE; Murray TG; Kim JE; Vilar NF; Pereira MB; Jorge R
    Ophthalmology; 2003 Apr; 110(4):709-13; discussion 713-4. PubMed ID: 12689890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes.
    Ando F; Ohba N; Touura K; Hirose H
    Retina; 2007 Jan; 27(1):37-44. PubMed ID: 17218913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis.
    Androudi S; Ahmed M; Fiore T; Brazitikos P; Foster CS
    J Cataract Refract Surg; 2005 Mar; 31(3):472-8. PubMed ID: 15811733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitrectomy in uveitis patients.
    Pion B; Valyi ZS; Janssens X; Koch P; Libert J; Caspers L; Willermain F
    Bull Soc Belge Ophtalmol; 2013; (322):55-61. PubMed ID: 24923083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RECURRENT OPENING AND CLOSURE OF MACULAR HOLE AFTER PARS PLANA VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT.
    Ozdemir E; Ozdek S
    Retin Cases Brief Rep; 2020; 14(4):331-333. PubMed ID: 29315126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Vitrectomy in the Management of Uveitis: Opportunities and Challenges.
    Vithalani NM; Basu S
    Semin Ophthalmol; 2022; 37(7-8):820-829. PubMed ID: 35608546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes.
    Silva PS; Diala PA; Hamam RN; Arrigg PG; Shah ST; Murtha TL; Schlossman DK; Cavallerano JD; Sun JK; Aiello LP
    Retina; 2014 Oct; 34(10):1960-8. PubMed ID: 24830822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.
    Tranos P; Scott R; Zambarakji H; Ayliffe W; Pavesio C; Charteris DG
    Br J Ophthalmol; 2006 Sep; 90(9):1107-10. PubMed ID: 16723360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MACULAR HOLE AFTER PARS PLANA VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT.
    Medina CA; Ortiz AG; Relhan N; Smiddy WE; Townsend JH; Flynn HW
    Retina; 2017 Jun; 37(6):1065-1072. PubMed ID: 27755378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical features of macular pucker formation after pars plana vitrectomy for primary rhegmatogenous retinal detachment repair.
    Heo MS; Kim HW; Lee JE; Lee SJ; Yun IH
    Korean J Ophthalmol; 2012 Oct; 26(5):355-61. PubMed ID: 23060722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study.
    Shalaby O; Saeed A; Elmohamady MN
    Arq Bras Oftalmol; 2020; 83(5):402-409. PubMed ID: 33084818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of pars plana vitrectomy in the management of complicated uveitis.
    Heiligenhaus A; Bornfeld N; Foerster MH; Wessing A
    Br J Ophthalmol; 1994 Jul; 78(7):549-54. PubMed ID: 7918267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis.
    Wiechens B; Nölle B; Reichelt JA
    Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(7):474-81. PubMed ID: 11521690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. POSTERIOR VITREOUS DETACHMENT IN HIGHLY MYOPIC EYES UNDERGOING VITRECTOMY.
    Philippakis E; Couturier A; Gaucher D; Gualino V; Massin P; Gaudric A; Tadayoni R
    Retina; 2016 Jun; 36(6):1070-5. PubMed ID: 26669837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pars Plana Vitrectomy for the Treatment of Uveitis.
    Henry CR; Becker MD; Yang Y; Davis JL
    Am J Ophthalmol; 2018 Jun; 190():142-149. PubMed ID: 29601822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
    Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
    Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.